• Something wrong with this record ?

Monitoring of nucleophosmin oligomerization in live cells

A. Holoubek, P. Herman, J. Sýkora, B. Brodská, J. Humpolíčková, M. Kráčmarová, D. Gášková, M. Hof, K. Kuželová,

. 2018 ; 6 (3) : 035016. [pub] 20180629

Language English Country England, Great Britain

Document type Journal Article

Grant support
NV16-30268A MZ0 CEP Register

Oligomerization plays a crucial role in the function of nucleophosmin (NPM), an abundant nucleolar phosphoprotein. Two dual-color methods based on modern fluorescence confocal microscopy are applied for tracking NPM aggregates in live cells: cross-correlation Number and Brightness analysis (ccN&B) combined with pulsed interleaved excitation (PIE) and fluorescence-lifetime imaging microscopy (FLIM) utilizing resonance energy transfer (FRET). HEK-293T cells were transfected with mixture of plasmids designed for tagging with fluorescent proteins so that the cells express mixed population of NPM labeled either with eGFP or mRFP1. We observe joint oligomers formed from the fluorescently labeled NPM. Having validated the in vivo methods, we study an effect of substitutions in cysteine 21 (Cys21) of the NPM N-terminus on the oligomerization to demonstrate applicability of the methods. Inhibitory effect of mutations of the Cys21 to nonpolar Ala or to aromatic Phe on the oligomerization was reported in literature using in vitro semi-native electrophoresis. However, we do not detect any break-up of the joint NPM oligomers due to the Cys21 mutations in live cells. In vivo microscopy observations are supported by an in vitro method, the GFP-Trap immunoprecipitation assay. Our results therefore show importance of utilizing several methods for detection of biologically relevant protein aggregates. In vivo monitoring of the NPM oligomerization, a potential cancer therapy target, by the presented methods offers a new way to monitor effects of drugs that are tested as NPM oligomerization inhibitors directly in live cells.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19000646
003      
CZ-PrNML
005      
20190122124205.0
007      
ta
008      
190107s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1088/2050-6120/aaccb9 $2 doi
035    __
$a (PubMed)29901450
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Holoubek, Aleš $u Department of Proteomics, Institute of Hematology and Blood Transfusion, U Nemocnice 2094/1, 128 20 Praha 2, Czechia.
245    10
$a Monitoring of nucleophosmin oligomerization in live cells / $c A. Holoubek, P. Herman, J. Sýkora, B. Brodská, J. Humpolíčková, M. Kráčmarová, D. Gášková, M. Hof, K. Kuželová,
520    9_
$a Oligomerization plays a crucial role in the function of nucleophosmin (NPM), an abundant nucleolar phosphoprotein. Two dual-color methods based on modern fluorescence confocal microscopy are applied for tracking NPM aggregates in live cells: cross-correlation Number and Brightness analysis (ccN&B) combined with pulsed interleaved excitation (PIE) and fluorescence-lifetime imaging microscopy (FLIM) utilizing resonance energy transfer (FRET). HEK-293T cells were transfected with mixture of plasmids designed for tagging with fluorescent proteins so that the cells express mixed population of NPM labeled either with eGFP or mRFP1. We observe joint oligomers formed from the fluorescently labeled NPM. Having validated the in vivo methods, we study an effect of substitutions in cysteine 21 (Cys21) of the NPM N-terminus on the oligomerization to demonstrate applicability of the methods. Inhibitory effect of mutations of the Cys21 to nonpolar Ala or to aromatic Phe on the oligomerization was reported in literature using in vitro semi-native electrophoresis. However, we do not detect any break-up of the joint NPM oligomers due to the Cys21 mutations in live cells. In vivo microscopy observations are supported by an in vitro method, the GFP-Trap immunoprecipitation assay. Our results therefore show importance of utilizing several methods for detection of biologically relevant protein aggregates. In vivo monitoring of the NPM oligomerization, a potential cancer therapy target, by the presented methods offers a new way to monitor effects of drugs that are tested as NPM oligomerization inhibitors directly in live cells.
650    _2
$a rezonanční přenos fluorescenční energie $x metody $7 D031541
650    _2
$a lidé $7 D006801
650    _2
$a jaderné proteiny $x metabolismus $7 D009687
650    _2
$a proteinové agregáty $x fyziologie $7 D066329
655    _2
$a časopisecké články $7 D016428
700    1_
$a Herman, Petr
700    1_
$a Sýkora, Jan
700    1_
$a Brodská, Barbora
700    1_
$a Humpolíčková, Jana
700    1_
$a Kráčmarová, Markéta
700    1_
$a Gášková, Dana
700    1_
$a Hof, Martin
700    1_
$a Kuželová, Kateřina
773    0_
$w MED00196698 $t Methods and applications in fluorescence $x 2050-6120 $g Roč. 6, č. 3 (2018), s. 035016
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29901450 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20190122124425 $b ABA008
999    __
$a ok $b bmc $g 1364686 $s 1038769
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 6 $c 3 $d 035016 $e 20180629 $i 2050-6120 $m Methods and applications in fluorescence $n Methods Appl Fluoresc $x MED00196698
GRA    __
$a NV16-30268A $p MZ0
LZP    __
$a Pubmed-20190107

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...